Basic concepts and directions in the radiation therapy quality assurance processes of clinical trials.
Assurance qualité
Clinical trial
Drug
Essai clinique
Innovation
Médicament
Outcomes
Pronostic
Quality assurance
Radiation therapy
Radiothérapie
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
03
07
2023
accepted:
07
07
2023
medline:
12
9
2023
pubmed:
5
8
2023
entrez:
4
8
2023
Statut:
ppublish
Résumé
The radiation therapy quality assurance of clinical trials is internationally recognized as a key factor to control the quality of radiotherapy for its impact on clinical trial's goals. Quality assessment may be performed at different levels and by different means, which are now quite standardized. The optimal radiation therapy quality assurance of clinical trials trade-off to maintain accrual rates, radiotherapy quality and optimize clinical trial research processes is yet to be defined. This article addresses current definitions, processes, limitations and directions.
Identifiants
pubmed: 37541796
pii: S1278-3218(23)00143-9
doi: 10.1016/j.canrad.2023.07.001
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
464-468Informations de copyright
Copyright © 2023 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.